Gastric Cancer Diagnostic Procedure Market 2024 – By Industry Outlook, Future Trends, Growth Analysis And Forecast To 2033

The Gastric Cancer Diagnostic Procedure Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Gastric Cancer Diagnostic Procedure Market:
https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

According to The Business Research Company’s Gastric Cancer Diagnostic Procedure Global Market Report 2024, The gastric cancer diagnostic procedure market size has grown strongly in recent years. It will grow from $1.32 billion in 2023 to $1.43 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%.  The  growth in the historic period can be attributed to innovations in biopsy techniques, increased research funding, evolution of biomarker discovery, improved pathological analysis, shifts in screening guidelines..

The gastric cancer diagnostic procedure market size is expected to see strong growth in the next few years. It will grow to $1.88 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%.  The growth in the forecast period can be attributed to rise in point-of-care testing, introduction of novel biomarkers, shift towards personalized medicine, adoption of next-generation sequencing, enhanced endoscopic imaging modalities.. Major trends in the forecast period include integration of nanotechnology, adoption of big data analytics, application of microbiota analysis, increased patient-centric approaches, role of telehealth in diagnostics..

The increasing prevalence of gastrointestinal diseases is driving the growth of the gastric cancer diagnostic procedure market going forward. Gastrointestinal disorders refer to illnesses affecting the digestive system’s many sections and the supporting organs, including the liver and pancreas. A gastric cancer diagnostic procedure is used to treat stomach cancer which treats gastric cancer such as endoscopic and biopsy. Hence, the growing incidence of gastrointestinal diseases is fueling the expansion of the gastric cancer diagnostic procedure market. For instance, in August 2022, according to the report published by GI Associates & Endoscopy Center, a US-based medical facility specializing in gastroenterology services, a study that included 73,076 people from 33 nations, 40% of the subjects suffered from a functional gastrointestinal illness. Therefore, the increasing prevalence of gastrointestinal diseases contributes to the growth of the gastric cancer diagnostic procedure market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp

The gastric cancer diagnostic procedure market covered in this report is segmented –

1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue tests, Lab tests, In-vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types

2) By Symptom Type: Symptomatic, Asymptomatic

3) By Offering Type: Instruments, Reagents and Consumables, Services

4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid

5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer

Top Major Players
Pfizer Inc.
Johnson & Johnson Co
Hoffmann La Roche Ltd.
Merck & Co. Inc.
Bayer AG

Technological advancements are a key trend gaining popularity in the gastric cancer diagnostic market. Major companies operating in the gastric cancer diagnostic market are adopting new technologies to sustain their position in the market. For instance, in June 2022, Ibex Medical Analytics, an Israel-based AI-powered diagnostics provider for health organizations, launched Galen Gastric, the world’s first AI-powered solution for gastric cancer detection. Galen Gastric is an integrated diagnostic tool that helps pathologists identify stomach cancer, H. pylori, and other significant clinical findings while also facilitating quicker turnaround times and improved diagnostic workflows.

The gastric cancer diagnostic procedure market report table of contents includes:
1. Executive Summary
2. Gastric Cancer Diagnostic Procedure Market Characteristics
3. Gastric Cancer Diagnostic Procedure Market Trends And Strategies
4. Gastric Cancer Diagnostic Procedure Market – Macro Economic Scenario
5. Global Gastric Cancer Diagnostic Procedure Market Size and Growth
…………………
32. Global Gastric Cancer Diagnostic Procedure Market Competitive Benchmarking
33. Global Gastric Cancer Diagnostic Procedure Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Gastric Cancer Diagnostic Procedure Market
35. Gastric Cancer Diagnostic Procedure Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model